TEVA PHARMS USA FDA Approval ANDA 211032

ANDA 211032

TEVA PHARMS USA

FDA Drug Application

Application #211032

Application Sponsors

ANDA 211032TEVA PHARMS USA

Marketing Status

Discontinued001

Application Products

001SUSPENSION;ORAL2.5MG/ML0CLOBAZAMCLOBAZAM

FDA Submissions

UNKNOWN; ORIG1AP2020-01-31STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

TEVA PHARMS USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211032
            [companyName] => TEVA PHARMS USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLOBAZAM","activeIngredients":"CLOBAZAM","strength":"2.5MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/31\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-01-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.